blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0982032

EP0982032 - Use of a sterol compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production [Right-click to bookmark this link]
Former [2000/09]Use of a ring system compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production
[2002/44]
StatusNo opposition filed within time limit
Status updated on  11.06.2004
Database last updated on 02.08.2024
Most recent event   Tooltip11.06.2004No opposition filed within time limitpublished on 28.07.2004  [2004/31]
Applicant(s)For all designated states
Sterix Limited
The Magdalen Centre, Robert Robinson Avenue, The Oxford Science Park
Oxford OX4 4GA / GB
[2003/32]
Former [2000/09]For all designated states
Sterix Limited
The Magdalen Centre Robert Robinson Avenue The Oxford Science Park
Oxford OX4 4GA / GB
Inventor(s)01 / Reed, Michael John
42 Wimborne Gardens
London W13 8BZ / GB
02 / Potter, Barry Victor Lloyd
95 Dovers Park, Bathford
Bath, Avon BA1 7UE / GB
[2000/09]
Representative(s)Harding, Charles Thomas, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2000/09]Harding, Charles Thomas, et al
D. Young & Co. 21 New Fetter Lane
London EC4A 1DA / GB
Application number, filing date99203449.628.08.1992
[2000/09]
Priority number, dateGB1991001847829.08.1991         Original published format: GB 9118478
[2000/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0982032
Date:01.03.2000
Language:EN
[2000/09]
Type: A3 Search report 
No.:EP0982032
Date:20.03.2002
[2002/12]
Type: B1 Patent specification 
No.:EP0982032
Date:06.08.2003
Language:EN
[2003/32]
Search report(s)(Supplementary) European search report - dispatched on:EP01.02.2002
ClassificationIPC:C07J41/00, A61K31/565, A61P5/32
[2002/12]
CPC:
A61K31/565 (EP,US); C07J41/00 (KR); A61P35/00 (EP);
A61P43/00 (EP); A61P5/30 (EP); A61P5/32 (EP);
A61P5/36 (EP); C07J41/0033 (EP,US); C07J41/0072 (EP,US) (-)
Former IPC [2000/09]A61K31/565
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   SE [2000/09]
TitleGerman:Verwendung einer Sulfamat-Ester enthaltenden Sterolverbindung zur Herstellung eines Arzneimittels zur Kontrolle der Östrogenproduktion[2002/44]
English:Use of a sterol compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production[2002/44]
French:Application d'un composé sterol contenant un groupement ester de sulphamate pour obtenir un médicament pour le controle de la production des oestrogènes[2002/44]
Former [2000/09]Verwendung einer Sulfamat-Ester enthaltenden Ringsystemverbindung zur Herstellung eines Arzneimittels zur Kontrolle der Östrogenproduktion
Former [2000/09]Use of a ring system compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production
Former [2000/09]Application d'un composé à système cyclique contenant un groupement ester de sulphamate pour obtenir un médicament pour le controle de la production des oestrogènes
Examination procedure04.11.1999Examination requested  [2000/09]
05.11.2001Request for accelerated examination filed
19.07.2002Despatch of a communication from the examining division (Time limit: M04)
19.07.2002Decision about request for accelerated examination - accepted: Yes
30.08.2002Reply to a communication from the examining division
07.02.2003Communication of intention to grant the patent
23.05.2003Fee for grant paid
23.05.2003Fee for publishing/printing paid
Parent application(s)   TooltipEP92918285.5  / EP0641355
Opposition(s)07.05.2004No opposition filed within time limit [2004/31]
Fees paidRenewal fee
04.11.1999Renewal fee patent year 03
04.11.1999Renewal fee patent year 04
04.11.1999Renewal fee patent year 05
04.11.1999Renewal fee patent year 06
04.11.1999Renewal fee patent year 07
04.11.1999Renewal fee patent year 08
11.08.2000Renewal fee patent year 09
02.08.2001Renewal fee patent year 10
07.08.2002Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XA]DD114806  (S. SCHARZ) [X] 2-13 * whole document, particularly example 10 * [A] 1;
 [XA]  - "STEROIDE SULFONYLOXYDERIVATE VON OSTROGENEN", PHARMAZIE, VEB VERLAG VOLK UND GESUNDHEIT. BERLIN, DD, (1975), vol. 30, no. 1, ISSN 0031-7144, pages 17 - 21, XP002026378 [X] 2-13 * whole document, particular page 18, column 1, lines 20-37 * [A] 1
 [XA]  - TOWNSLEY J D ET AL, "Structure Activity Correlations for Steroid Inhibition of Human Placental Steroid-3-Sulfatase", RESEARCH ON STEROIDS. TRANSACTIONS OF HTE MEETING OF THE INTERNATIONAL STUDY GROUP FOR STEROIDS HORMONES, XX, XX, (1973), vol. 5, pages 73 - 78, XP002176603 [X] 2-13 * the whole document * [A] 1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.